Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Water Street Healthcare Partners is a leading private equity firm focused exclusively on healthcare. Since its founding in 2005, it has completed more than 165 investments and strategic acquisitions across over 48 healthcare companies. The firm's investments span medical products and diagnostics, pharmaceutical and life sciences services/products, specialty distribution, and outsourced healthcare services. It partners with both established leaders and innovative growth-stage businesses to accelerate growth through capital deployment and strategic support.
The company does not directly conduct clinical trials or develop drugs but invests in firms that do.
Its approach emphasizes transformational growth by addressing critical needs in efficiency, access, patient outcomes—and it maintains long-term partnerships with major global healthcare players such as Johnson & Johnson and Medtronic.
Recent notable activity includes facilitating the combination of CXV Global and Panacea Technologies to create a global provider of automation/digitization solutions for life sciences operations.
As an investor rather than an operator or developer of therapies/devices directly:
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Water Street Healthcare Partners.